Major Pharmaceuticals Melatonin Tablets provide a clinical-grade portfolio of exogenous pineal hormone formulations engineered for institutional healthcare facilities, hospital pharmacies, long-term care units, and outpatient clinics. Encompassing targeted low-dose (1 mg), standard (3 mg), and high-strength (5 mg) potencies, this portfolio is formulated to support circadian rhythm regulation, sleep-wake cycle synchronization, and the management of transient insomnia or sleep disturbances in clinical environments. Manufactured in compliance with USP quality standards and assigned individual National Drug Codes (NDC), these products ensure accurate dispensing, precise inventory tracking, and seamless barcode medication administration (BCMA) across healthcare systems.
